Celldex Therapeutics, Inc. — DEF 14A Filings
31 DEF 14A filings on record
This page lists all DEF 14A filings submitted to the SEC by Celldex Therapeutics, Inc. (CLDX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Celldex Therapeutics, Inc. has filed 31 DEF 14A documents with the SEC since 2007. To view all SEC filings by Celldex Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-K405
10-Q
10-Q/A
144
3
4
4/A
424B1
424B2
424B3
424B5
425
5
8-A12G
8-A12G/A
8-K
8-K/A
ARS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFR14A
DEL AM
EFFECT
NT 10-K
NT 10-Q
POS AM
PRE 14A
REGDEX
S-3
S-3/A
S-3ASR
S-3MEF
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | FORM DEF 14A | 0001104659-25-036562 | Apr 21, 2025 | Jun 5, 2025 |
| DEF 14A | DEF 14A | 0001104659-24-051634 | Apr 25, 2024 | Jun 13, 2024 |
| DEF 14A | DEF 14A | 0001104659-23-049299 | Apr 25, 2023 | — |
| DEF 14A | DEF 14A | 0001104659-22-049942 | Apr 26, 2022 | Jun 16, 2022 |
| DEF 14A | DEF 14A | 0001104659-21-055589 | Apr 27, 2021 | Jun 17, 2021 |
| DEF 14A | DEF 14A | 0001047469-20-002644 | Apr 28, 2020 | Jun 18, 2020 |
| DEF 14A | DEF 14A | 0001047469-19-002607 | Apr 26, 2019 | Jun 19, 2019 |
| DEF 14A | DEF 14A | 0001047469-18-003326 | Apr 30, 2018 | Jun 13, 2018 |
| DEF 14A | DEF 14A | 0001047469-17-003056 | Apr 28, 2017 | Jun 15, 2017 |
| DEF 14A | DEF 14A | 0001047469-16-012401 | Apr 21, 2016 | Jun 8, 2016 |
| DEF 14A | DEF 14A | 0001047469-15-003819 | Apr 23, 2015 | Jun 10, 2015 |
| DEF 14A | DEF 14A | 0001047469-14-003582 | Apr 9, 2014 | May 28, 2014 |
| DEF 14A | DEF 14A | 0001047469-13-004692 | Apr 23, 2013 | Jun 12, 2013 |
| DEF 14A | DEF 14A | 0001047469-12-004633 | Apr 24, 2012 | Jun 13, 2012 |
| DEF 14A | DEF 14A | 0001047469-11-004060 | Apr 26, 2011 | Jun 15, 2011 |
| DEF 14A | DEF 14A | 0001047469-10-006977 | Aug 4, 2010 | Sep 15, 2010 |
| DEF 14A | DEF 14A | 0001047469-09-009714 | Nov 6, 2009 | Dec 16, 2009 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001206774-08-001493 | Aug 25, 2008 | Sep 25, 2008 |
| DEF 14A | NOTICE OF PROXY STATEMENT | 0001206774-07-001070 | Apr 20, 2007 | May 17, 2007 |
| DEF 14A | — | 0001206774-06-000832 | Apr 19, 2006 | May 18, 2006 |
| DEF 14A | — | 0001206774-05-000684 | Apr 22, 2005 | May 19, 2005 |
| DEF 14A | — | 0001145443-04-000574 | Apr 12, 2004 | May 13, 2004 |
| DEF 14A | — | 0001206774-03-000232 | Apr 2, 2003 | May 15, 2003 |
| DEF 14A | DEFINITIVE PROXY | 0000950136-02-000857 | Mar 28, 2002 | Apr 1, 2002 |
| DEF 14A | — | 0001053949-01-500039 | Apr 3, 2001 | May 21, 2001 |
| DEF 14A | FORM DEF 14A | 0000912057-00-014070 | Mar 28, 2000 | May 8, 2000 |
| DEF 14A | AVANT IMMUNOTHERAPEUTICS, INC. FORM DEF 14A | 0001029869-99-000403 | Apr 1, 1999 | May 6, 1998 |
| DEF 14A | PROXY | 0001029869-98-000494 | Apr 13, 1998 | Dec 31, 1997 |
| DEF 14A | PROXY STATEMENT | 0001029869-97-000487 | Apr 11, 1997 | Dec 31, 1996 |
| DEF 14A | T CELL SCIENCES, INC. | 0000950135-96-001733 | Apr 15, 1996 | May 21, 1996 |
| DEF 14A | T CELL SCIENCES, INC. | 0000950135-95-000894 | Apr 6, 1995 | May 18, 1995 |